Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2

por Fedier, A, Ruefenacht, U B, Schwarz, V A, Haller, U, Fink, D
Publicado 2002

Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.

por Stein, B., Momburg, F., Schwarz, V., Schlag, P., Moldenhauer, G., Möller, P.
Publicado 1988

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells

por Schwarz, V A, Hornung, R, Fedier, A, Fehr, M K, Walt, H, Haller, U, Fink, D
Publicado 2002

The glycosphingolipid P(1) is an ovarian cancer-associated carbohydrate antigen involved in migration

por Jacob, F, Anugraham, M, Pochechueva, T, Tse, B W C, Alam, S, Guertler, R, Bovin, N V, Fedier, A, Hacker, N F, Huflejt, M E, Packer, N, Heinzelmann-Schwarz, V A
Publicado 2014

A distinct molecular profile associated with mucinous epithelial ovarian cancer

por Heinzelmann-Schwarz, V A, Gardiner-Garden, M, Henshall, S M, Scurry, J P, Scolyer, R A, Smith, A N, Bali, A, Bergh, P Vanden, Baron-Hay, S, Scott, C, Fink, D, Hacker, N F, Sutherland, R L, O'Brien, P M
Publicado 2006

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

por O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, D I, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L
Publicado 2008

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

por O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Murali, R, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, Di, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L
Publicado 2008

A Precision Measurement of pp Elastic Scattering Cross Sections at Intermediate Energies

por Albers, D, Bauer, F, Bisplinghoff, J, Bollmann, R, Büsser, K, Busch, M, Daniel, R, Diehl, O, Dohrmann, F, Engelhardt, H P, Ernst, J, Eversheim, P D, Gasthuber, M, Gebel, R, Greiff, J, Gross, A, Gross-Hardt, R, Heider, S, Heine, A, Hinterberger, F, Hueskes, T, Igelbrink, M, Jeske, M, Langkau, R, Lindlein, J, Maier, R, Maschuw, R, Mosel, F, Prasuhn, D, Rohdjess, H, Rosendaal, D, Von Rossen, P, Scheid, N, Schirm, N, Schulz-Rojahn, M, Schwandt, F, Schwarz, V, Scobel, W, Thomas, S, Trelle, H J, Weise, E, Wellinghausen, A, Woller, K, Ziegler, R
Publicado 2004

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/...

por Colombo, N., Gadducci, A., Sehouli, J., Rulli, E., Mäenpää, J., Sessa, C., Montes, A., Ottevanger, N. B., Berger, R., Vergote, I., D’Incalci, M., Churruca Galaz, C., Chekerov, R., Nyvang, G. B., Riniker, S., Herbertson, R., Fossati, R., Barretina-Ginesta, M. P., Deryal, M., Mirza, M. R., Biagioli, E., Iglesias, M., Funari, G., Romeo, M., Tasca, G., Pardo, B., Tognon, G., Rubio-Pérez, M. J., DeCensi, A., De Giorgi, U., Zola, P., Benedetti Panici, P., Aglietta, M., Arcangeli, V., Zamagni, C., Bologna, A., Westermann, A., Heinzelmann-Schwarz, V., Tsibulak, I., Wimberger, P., Poveda, A.
Publicado 2023